Search hospitals > Kansas > Mission
University of Kansas Medical Center
Claim this profileMission, Kansas 66205
Global Leader in Leukemia
Conducts research for Myeloid Leukemia
Conducts research for Acute Myeloid Leukemia
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
59 reported clinical trials
5 medical researchers
Summary
University of Kansas Medical Center is a medical facility located in Mission, Kansas. This center is recognized for care of Leukemia, Myeloid Leukemia, Acute Myeloid Leukemia, Lung Cancer, Non-Small Cell Lung Cancer and other specialties. University of Kansas Medical Center is involved with conducting 59 clinical trials across 78 conditions. There are 5 research doctors associated with this hospital, such as Andrea D. Jewell, Raed Al-Rajabi, Steve Williamson, MD, and OBI Investigator Site.Area of expertise
1Leukemia
Global LeaderPhiladelphia chromosome positive
CD19 positive
2Myeloid Leukemia
Top PIs
Andrea D. JewellUniversity of Kansas Cancer Center4 years of reported clinical research
Expert in Ovarian Cancer
Studies Fallopian Tube Cancer
17 reported clinical trials
39 drugs studied
Raed Al-RajabiHaysMed University of Kansas Health System1 year of reported clinical research
Studies Cancer
Studies Colorectal Cancer
10 reported clinical trials
15 drugs studied
Steve Williamson, MDThe University of Kansas Cancer Center (KUCC)2 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Bladder Cancer
5 reported clinical trials
8 drugs studied
OBI Investigator SiteKaiser Permanente Medical Center6 years of reported clinical research
Studies Breast Cancer
Studies Pancreatic Adenocarcinoma
2 reported clinical trials
3 drugs studied
Clinical Trials running at University of Kansas Medical Center
Cancer
Liver Cancer
Multiple Myeloma
Breast Cancer
Tumors
Bladder Cancer
Plasma Cell Neoplasms
Polycythemia Vera
Fallopian Tube Cancer
Ovarian Neoplasms
MRTX849
for Cancer
This trial is testing a new pill called MRTX849 (adagrasib) for patients with advanced cancers that have a specific genetic change called KRAS G12C. The pill aims to block this change and stop the cancer from growing. Adagrasib is similar to another approved treatment and is intended for patients with this genetic change who have already received other treatments.
Recruiting1 award Phase 1 & 24 criteria
CRS-HIPEC
for Colorectal Cancer
The purpose of this trial is to compare the morbidity and mortality of CRS-HIPEC using mitomycin-C versus melphalan for colorectal peritoneal carcinomatosis. Morbidity and mortality will measured using the Comprehensive Complication Index (CCI) score, Common terminology criteria for adverse events (CTCAE version 4.03), and the Clavien-Dindo Classification.
Recruiting1 award Phase 2
ECT204 T-Cell Therapy
for Liver Cancer
This trial is testing a new treatment where a patient's immune cells are modified to better fight liver cancer. It is for adults with a specific type of liver cancer who haven't had success with other treatments. The modified cells are designed to find and kill cancer cells with a particular marker.
Recruiting1 award Phase 28 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of Kansas Medical Center?
University of Kansas Medical Center is a medical facility located in Mission, Kansas. This center is recognized for care of Leukemia, Myeloid Leukemia, Acute Myeloid Leukemia, Lung Cancer, Non-Small Cell Lung Cancer and other specialties. University of Kansas Medical Center is involved with conducting 59 clinical trials across 78 conditions. There are 5 research doctors associated with this hospital, such as Andrea D. Jewell, Raed Al-Rajabi, Steve Williamson, MD, and OBI Investigator Site.